136 related articles for article (PubMed ID: 24186881)
1. Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.
Anderssohn M; McLachlan S; Lüneburg N; Robertson C; Schwedhelm E; Williamson RM; Strachan MW; Ajjan R; Grant PJ; Böger RH; Price JF
Diabetes Care; 2014; 37(3):846-54. PubMed ID: 24186881
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
Lüneburg N; Lieb W; Zeller T; Chen MH; Maas R; Carter AM; Xanthakis V; Glazer NL; Schwedhelm E; Seshadri S; Ikram MA; Longstreth WT; Fornage M; König IR; Loley C; Ojeda FM; Schillert A; Wang TJ; Sticht H; Kittel A; König J; Benjamin EJ; Sullivan LM; Bernges I; Anderssohn M; Ziegler A; Gieger C; Illig T; Meisinger C; Wichmann HE; Wild PS; Schunkert H; Psaty BM; Wiggins KL; Heckbert SR; Smith N; Lackner K; Lunetta KL; Blankenberg S; Erdmann J; Munzel T; Grant PJ; Vasan RS; Böger RH
Circ Cardiovasc Genet; 2014 Dec; 7(6):864-72. PubMed ID: 25245031
[TBL] [Abstract][Full Text] [Related]
3. AGXT2 and DDAH-1 genetic variants are highly correlated with serum ADMA and SDMA levels and with incidence of coronary artery disease in Egyptians.
Amir M; Hassanein SI; Abdel Rahman MF; Gad MZ
Mol Biol Rep; 2018 Dec; 45(6):2411-2419. PubMed ID: 30284143
[TBL] [Abstract][Full Text] [Related]
4. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
Tanhäuserová V; Tomandl J; Pácal L; Klepárník M; Malúšková D; Bartáková V; Kuricová K; Rehořová J; Stěpánková S; Svojanovský J; Olšovský J; Bělobrádková J; Krusová D; Jurajda M; Mužík J; Pavlík T; Kaňková K
Kidney Blood Press Res; 2012; 36(1):200-8. PubMed ID: 23147199
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.
Dimitroulas T; Hodson J; Panoulas VF; Sandoo A; Smith J; Kitas G
Amino Acids; 2017 Jun; 49(6):1133-1141. PubMed ID: 28357606
[TBL] [Abstract][Full Text] [Related]
6. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes.
Abhary S; Burdon KP; Kuot A; Javadiyan S; Whiting MJ; Kasmeridis N; Petrovsky N; Craig JE
PLoS One; 2010 Mar; 5(3):e9462. PubMed ID: 20209122
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
Jud P; Hafner F; Verheyen N; Gary T; Meinitzer A; Brodmann M; Seinost G; Hackl G
Heart Vessels; 2018 Dec; 33(12):1453-1462. PubMed ID: 29946762
[TBL] [Abstract][Full Text] [Related]
8. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
Lu TM; Lin SJ; Lin MW; Hsu CP; Chung MY
Cardiovasc Diabetol; 2011 Feb; 10():16. PubMed ID: 21303562
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.
Seppälä I; Kleber ME; Lyytikäinen LP; Hernesniemi JA; Mäkelä KM; Oksala N; Laaksonen R; Pilz S; Tomaschitz A; Silbernagel G; Boehm BO; Grammer TB; Koskinen T; Juonala M; Hutri-Kähönen N; Alfthan G; Viikari JS; Kähonen M; Raitakari OT; März W; Meinitzer A; Lehtimäki T;
Eur Heart J; 2014 Feb; 35(8):524-31. PubMed ID: 24159190
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Lind L; Ingelsson E; Kumar J; Syvänen AC; Axelsson T; Teerlink T
Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
[TBL] [Abstract][Full Text] [Related]
12. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
[TBL] [Abstract][Full Text] [Related]
13. Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood.
Hannemann J; Zummack J; Hillig J; Rendant-Gantzberg L; Böger R
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207213
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
Javadiyan S; Burdon KP; Whiting MJ; Abhary S; Straga T; Hewitt AW; Mills RA; Craig JE
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1923-7. PubMed ID: 22395885
[TBL] [Abstract][Full Text] [Related]
15. Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study.
Au Yeung SL; Lin SL; Lam HS; Schooling CM
Am Heart J; 2016 Dec; 182():54-61. PubMed ID: 27914500
[TBL] [Abstract][Full Text] [Related]
16. Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers.
Kittel A; Müller F; König J; Mieth M; Sticht H; Zolk O; Kralj A; Heinrich MR; Fromm MF; Maas R
PLoS One; 2014; 9(2):e88544. PubMed ID: 24586340
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.
Schlesinger S; Sonntag SR; Lieb W; Maas R
PLoS One; 2016; 11(11):e0165811. PubMed ID: 27812151
[TBL] [Abstract][Full Text] [Related]
19. Dimethylarginines correlate to common carotid artery wall layer dimensions and cardiovascular risk factors in pregnant women with/without preeclampsia: A group comparative study.
Akhter T; Wikström G; Larsson M; Bondesson U; Hedeland M; Naessen T
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():288-293. PubMed ID: 33498001
[TBL] [Abstract][Full Text] [Related]
20. Sequence Variation in the DDAH1 Gene Predisposes for Delayed Cerebral Ischemia in Subarachnoidal Hemorrhage.
Hannemann J; Appel D; Seeberger-Steinmeister M; Brüning T; Zummack J; Böger R
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33271854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]